André Fe
About
In The Last Decade
André Fe
14 papers receiving 991 citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Health 583
- Epidemiology 456
- Infectious Diseases 358
- Immunology 122
- Sociology and Political Science 98
Countries citing papers authored by André Fe
This map shows the geographic impact of André Fe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Fe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Fe more than expected).
Fields of papers citing papers by André Fe
This network shows the impact of papers produced by André Fe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Fe. The network helps show where André Fe may publish in the future.
Co-authorship network of co-authors of André Fe
This figure shows the co-authorship network connecting the top 25 collaborators of André Fe. A scholar is included among the top collaborators of André Fe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Fe. André Fe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Vaccination greatly reduces disease, disability, death and inequity worldwide breakdown → | 854 |
| 3 | How the research-based industry approaches vaccine development and establishes priorities. | 33 |
| 4 | Immunogenicity of an inactivated hepatitis A vaccine in healthy children: two years' follow-up. | 2 |
| 5 | Clinical experience with a yeast-derived hepatitis B vaccine. | 32 |
| 6 | Clinical experience with a recombinant DNA hepatitis B vaccine. | 11 |
| 7 | Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men. | 4 |
| 8 | Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. | 14 |
| 9 | Worldwide experience with the Oka-strain live varicella vaccine. | 23 |
| 10 | Summary of clinical studies with the Oka live varicella vaccine produced by Smith Kline-RIT. | 12 |
| 11 | Field trial of a heat-stable measles vaccine in Papua New Guinea. | 4 |
| 12 | Protective efficacy of a bivalent (A + C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. | 25 |
| 13 | Poliomyelitis vaccines in Belgium: 20 years of experience. | 4 |
| 14 | A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers. | 28 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.